| | |
CUSIP No. 204448104 | | Page 11 of 22 |
Item 3. | Source and Amount of Funds or Other Consideration |
Pursuant to the CSP Transaction (as defined in Item 6 below) between Andean and a financial institution (“Dealer”), Dealer is obligated to deliver to Andean 30,000,000 (subject to reduction in the case of an early termination) ADSs for a purchase price to be determined over the term of the CSP Transaction. Pursuant to the CSP Transaction, Andean prepaid the maximum purchase price for the ADSs and certain non-refundable fees with working capital. Once the aggregate purchase price is known, Dealer will pay Andean an amount equal to the amount, if any, by which the Prepayment Amount (as defined in Item 6 below) exceeds the aggregate purchase price.
Item 4. | Purpose of the Transaction |
The information set forth or incorporated by reference in Item 6 is incorporated by reference in its entirety into this Item 4.
On December 12, 2023, representatives of the Reporting Persons informed the Issuer of their investment in the Issuer, and on that day and the following days the Reporting Persons and the Issuer discussed a proposal by the Reporting Persons to develop a framework of collaboration for the benefit of the Issuer and its stakeholders, including with respect to strategic, operational and financial matters, including a proposal for Antofagasta to be represented on the board of directors of the Issuer (the “Board”). The Reporting Persons and the Issuer have not reached agreement on these matters as of the date of this filing.
The Reporting Persons may continue to discuss the foregoing matters and/or consider and/or develop other plans and/or make other proposals (whether preliminary or final) with respect to, among other things, potential changes in the Issuer’s business, operations, management, governance, organizational documents, size and composition of the Board and the election, term and replacement of members of the Board, ownership, capital or corporate structure, sale transactions, dividend policy, strategy and plans, as well as potential financings, business combinations, strategic alternatives and other matters concerning the Issuer. The Reporting Persons may communicate with the Board and members of the Issuer’s management team or other stakeholders or third parties regarding the foregoing. The Reporting Persons may change their intentions with respect to any and all matters referred to in this Item 4 at any time. The Reporting Persons may also take steps to explore and prepare for various plans and actions, and propose transactions, before forming an intention to engage in such plans or actions or proceed with such actions or transactions.
Other than as described above, none of the Reporting Persons nor, to the best knowledge of each of the Reporting Persons, without independent verification, any of the persons listed in Schedules 1-7 hereto, currently has any plans or proposals that relate to, or would result in, any of the matters listed in Items 4(a)–(j) of Schedule 13D, although the Reporting Persons may, at any time and from time to time, review or reconsider their position and/or change their purpose and/or formulate plans or proposals with respect thereto. As a result of these activities, one or more of the Reporting Persons may suggest or take a position with respect to potential changes in the operations, management or capital structure of the Issuer as a means of enhancing shareholder value. Such suggestions or positions may include one or more plans or proposals that relate to or would result in any of the actions required to be reported herein, including, without limitation, such matters as acquiring additional securities of the Issuer or disposing of securities of the Issuer; entering into an extraordinary corporate transaction such as a merger, reorganization or liquidation, involving the Issuer or any of its subsidiaries; selling or transferring a material amount of assets of the Issuer or any of its subsidiaries; changing the present Board or management of the Issuer, including changing the number or term of or replacing directors or filling any existing vacancies on the Board; materially changing the present capitalization or dividend policy of the Issuer; materially changing the Issuer’s business or corporate structure; changing the Issuer’s certificate of incorporation, bylaws or instruments corresponding thereto or taking other actions which may impede the acquisition of control of the Issuer by any person; causing a class of securities of the Issuer to be delisted from a national securities exchange or to cease to be authorized to be quoted in an interdealer quotation system of a registered national securities association; causing a class of equity securities of the Issuer to become eligible for termination of registration pursuant to Section 12(g)(4) of the Securities Act of 1933, as amended; and taking any action similar to any of those enumerated above.
Item 5. | Interests in Securities of the Issuer |
(a)-(b) See pages 2-9 of this Schedule 13D for the aggregate number and percentage of Common Shares beneficially owned by each Reporting Person, the number of Common Shares as to which there is sole or shared power to vote, or to direct the vote, and sole or shared power to dispose or to direct the disposition. As of the date hereof, the Reporting Persons may be deemed to be the beneficial owners of 48,058,225 Common Shares represented by ADSs. Of the Common Shares beneficially owned, (i) 18,058,225 Common Shares, representing approximately 7.1% of the Issuer’s outstanding shares are held by Andean on the date hereof, and (ii) 30,000,000 Common Shares, represented by 30,000,000 ADSs underlying the CSP Transaction, representing approximately 11.8% of the Issuer’s outstanding shares, may be delivered to Andean subject to the completion of the CSP Transaction and potential reduction as a result of an early termination as described in Item 6 below. All percentages set forth in this Schedule 13D are based upon the Issuer’s reported 253,715,190 Common Shares outstanding as of March 31, 2023 as reported in the Issuer’s Form 20-F for the fiscal year ended December 31, 2022.